Nuveen’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
130,346
+50,126
+62% +$103K ﹤0.01% 3083
2025
Q4
$225K Sell
80,220
-114,090
-59% -$265K ﹤0.01% 3114
2025
Q3
$400K Sell
194,310
-365,959
-65% -$1.01M ﹤0.01% 2976
2025
Q2
$1.76M Sell
560,269
-297,301
-35% -$907K ﹤0.01% 2359
2025
Q1
$2.69M Buy
857,570
+270,954
+46% +$1.07M ﹤0.01% 2208
2024
Q4
$2.55M Buy
586,616
+248,850
+74% +$778K ﹤0.01% 2281
2024
Q3
$902K Buy
337,766
+284,650
+536% +$672K ﹤0.01% 2806
2024
Q2
$118K Buy
+53,116
New +$200K ﹤0.01% 3297
2022
Q2
Sell
-249,912
Closed -$595K 3289
2022
Q1
$595K Sell
249,912
-102,755
-29% -$363K ﹤0.01% 2963
2021
Q4
$1.88M Buy
352,667
+116,890
+50% +$697K ﹤0.01% 2592
2021
Q3
$1.62M Buy
235,777
+41,536
+21% +$261K ﹤0.01% 2772
2021
Q2
$1.29M Buy
+194,241
New +$1.65M ﹤0.01% 2907

Other funds holding CRDF